The Clinical, Medical and Regulatory (CMR) department at Novo Nordisk is one of the most diverse and collaborative groups within the organization. From health-care-provider interactions and developing and implementing regulatory strategies with the FDA to providing medical education and collecting data to support efficacy and new product development, CMR is involved. The one thing that keeps us all marching to the same beat is our patient-centered focus. At Novo Nordisk, you will help patients around the world. As their needs evolve, so does our challenge to find better and more innovative ways to improve their quality of life. We’re changing lives for a living. Are you ready to make a difference?
The Novo Nordisk Real World Evidence / Clinical Data Science & Evidence - Fellow is responsible for supporting planning and execution of observational research / Real World Evidence (RWE) studies to support the Evidence Generation Plans (EGPs) for specific areas of the Novo Nordisk portfolio. In addition, the incumbent may also coordinate other activities including but not limited to cross-functional team meetings, project team meetings and observational study protocol reviews. One of the key responsibilities for the Fellow is leading specific research studies, as identified during the annual EGP process to support the product strategy; the Fellow may also be involved in activities surrounding study execution, for example supporting the communication of study results across the organization. This is an experiential fellowship, and the fellow will gain valuable experience in observing the development of product strategy, engaging with cross functional teams, leading research projects, coordinating/managing research vendors, & budget management.
The Fellow reports to the Executive Director RWE and works closely with all colleagues in both the RWE and broader Clinical Data Science & Evidence (CDSE) department.
Lead observational research projects and manage vendors, contracts and budget
Interact with cross functional stakeholders as part of research projects
Prepare protocols for internal approvals and engage reviewers during approval process
Responsible for data dissemination for specific research projects – includes external and internal stakeholders, managing the publication planning process
Work in close collaboration with colleagues within the CDSE team and also broader stakeholders across Novo Nordisk Inc for example Medical, Market Access, etc.
Communication and training of HEOR content
Be involved, as appropriate, in broader initiatives executed through the CDSE department to further support the processes and development of RWE
Throughout the fellowship the Fellow will also be expected to develop and publish a post-doc project; the RWD available to Novo Nordisk Inc will be available to support this project which will be anchored in the broader EGP
Approximately 10% overnight travel
A PhD (either completed or ABD), in appropriate field (heath economics, epidemiology, outcomes research, public health, health services research)
Strong communication and critical thinking skills
Works well under pressure, with initiative to take on unfamiliar tasks
We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark with our US headquarters located in Plainsboro, NJ. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure the diseases we treat. We employ more than 55,000 people in 80 offices around the world.
For over 100 years, we have been translating the unmet medical needs of people living with a serious chronic disease into innovative medicines and delivery systems, like our insulin pens. Our treatments today are benefiting millions of people living with diabetes, obesity, and rare blood and endocrine diseases. From our labs to our factory floors, we are discovering and developing innovative biological medicines and making them accessible to patients throughout the world. Our industry is dynamic. And the scientific understanding of the diseases we treat and the people living with them, improves every day. This is a constant reminder that what got us to where we are t...oday is not necessarily what will make us successful in the future. As an employer, we recognize the need to embrace experimentation and strive f or diversity and inclusion to help make better decisions by ensuring that multiple perspectives are considered. Together, we’re life changing.